share_log

Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Benzinga ·  Nov 1 21:15

Shares of Charter Communications, Inc. (NASDAQ:CHTR) rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and revenues.

Charter Communications reported fiscal third-quarter 2024 revenue growth of 1.6% year-on-year to $13.8 billion, beating the analyst consensus estimate of $13.7 billion. EPS of $8.82 beat the analyst consensus estimate of $8.67

Charter Communications shares rose 11.1% to $364.01 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Globalstar, Inc (NYSE:GSAT) gained 41.9% to $1.49 in pre-market trading after the company announced a proposed public offering.
  • Theriva Biologics, Inc. (NYSE:TOVX) rose 41.1% to $2.06 in pre-market trading after the company announced it was selected as a finalist for Merck KGaA's EMEA Advance Biotech Grant.
  • Athira Pharma, Inc. (NASDAQ:ATHA) shares surged 31.1% to $0.5610 in pre-market trading.
  • VS MEDIA Holdings Limited (NASDAQ:VSME) climbed 30% to $1.43 in pre-market trading after declining 11% on Thursday.
  • Atlassian Corporation (NASDAQ:TEAM) gained 22.5% to $231.06 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.
  • Nuburu, Inc. (NYSE:BURU) gained 18.6% to $0.5340 in pre-market trading.
  • Proto Labs, Inc. (NYSE:PRLB) gained 18.3% to $32.43 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance with its midpoint above estimates.
  • comScore, Inc. (NASDAQ:SCOR) shares rose 17.3% to $6.45 in pre-market trading.
  • Halozyme Therapeutics, Inc. (NASDAQ:HALO) gained 12.8% to $57.04 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY24 adjusted EPS guidance above estimates.

Losers

  • ESSA Pharma Inc. (NASDAQ:EPIX) shares dipped 69.2% to $1.60 in pre-market trading. ESSA Pharma terminated Phase 2 study evaluating Masofaniten combined with Enzalutamide in patients with mCRPC.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) fell 37.4% to $1.2207 in pre-market trading.
  • Elevai Labs Inc. (NASDAQ:ELAB) fell 35% to $0.0383 in pre-market trading.
  • MultiMetaVerse Holdings Limited (NASDAQ:MMV) declined 24.1% to $0.3331 in pre-market trading.
  • Arbe Robotics Ltd. (NASDAQ:ARBE) declined 18.7% to $1.4800 in pre-market trading after the company announced a public offering.
  • Advent Technologies Holdings, Inc. (NYSE:ADN) fell 15.8% to $1.9899 in pre-market trading after jumping around 34% on Thursday.
  • ASP Isotopes Inc. (NASDAQ:ASPI) fell 8.4% to $6.40 in pre-market trading after the company announced a proposed public offering.
  • BJ's Restaurants, Inc. (NASDAQ:BJRI) fell 6.3% to $34.75 in today's pre-market trading after the company announced worse-than-expected third-quarter EPS results.
  • nVent Electric plc (NYSE:NVT) shares fell 6.1% to $70.00 in pre-market trading after the company reported third-quarter results.
  • DigitalBridge Group, Inc. (NASDAQ:DBRG) declined 6% to $14.75 in pre-market trading after the company reported weaker-than-expected third-quarter results.

Now Read This:

  • S&P 500 Records Worst Session In Over A Month, Meta And Microsoft Tumble: Greed Index Moves To 'Fear' Zone
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment